Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Wesana Health Hldgs Stock News

WSNAFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0498

-0.03-37.81%

At close: -

$0.00900

-0.04-81.91%

After Hours: Oct 24, 4:00 PM EDT

Wesana Health Hldgs (WSNAF) Forecast

News

Earnings Wesana Health Hldgs (WSNAF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Wesana Health Hldgs Stock News | OTC:WSNAF | Benzinga

Get the latest news on Wesana Health Hldgs stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Wesana Health Hldgs performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, July 11, 2023

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Lara Goldstein

Tuesday, June 20, 2023

Psyched: $75M In Federal Funds, Gov. Polis Opens MAPS Event, CNN's Show, Dock Ellis' LSD Pitch & More
Lara Goldstein

Monday, June 12, 2023

Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific
Lara Goldstein

Monday, June 05, 2023

Disney, Amgen, First Republic, Psychedelics: How One Exec's Universal Deal-Making Approach Shapes Industries
Benzinga Cannabis

Thursday, April 13, 2023

EXCLUSIVE: Infrastructure Built For Healing: 'Consolidation And Legitimacy Are Crucial For Psychedelic Industry Growth'
Joana Scopel

Monday, April 03, 2023

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Javier Hasse

Wednesday, March 29, 2023

High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis
Lara Goldstein

Monday, March 27, 2023

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Lara Goldstein

Tuesday, March 21, 2023

Lucy Scientific Shares Trading Higher On Asset Purchase Agreement Of Psychedelic Assets From Wesana Health
Vuk Zdinjak

Thursday, October 20, 2022

NGOs Raise Money To Help Stem Opioid Addiction With Psychedelics Program
Lara Goldstein

Friday, September 02, 2022

Wesana Sells Clinic Management Services Organization To Strengthen Assets
Lara Goldstein

Tuesday, August 30, 2022

4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed
Lara Goldstein

Monday, April 25, 2022

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Natan Ponieman
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
Natan Ponieman

Friday, April 22, 2022

Can Psychedelics Be Used To Treat Traumatic Brain Injury? This Company Thinks So
Jacinta Sherris - Sponsored

Wednesday, April 20, 2022

EXCLUSIVE: Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury
Nicolás Jose Rodriguez

Tuesday, April 19, 2022

EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
Aaron Bry

Tuesday, March 22, 2022

Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
Natan Ponieman

Monday, March 14, 2022

Wesana Health One Step Closer To Clinical Trials Of Psilocybin And CBD Based Treatment Of Brain Injury Related MDD
Vuk Zdinjak

Tuesday, January 18, 2022

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
Natan Ponieman

Tuesday, January 11, 2022

Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
Natan Ponieman

Thursday, November 04, 2021

The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine
Natan Ponieman

Monday, October 18, 2021

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman

Wednesday, October 13, 2021

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman

Monday, September 20, 2021

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
Natan Ponieman

Tuesday, September 14, 2021

Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out
Natan Ponieman

Monday, August 16, 2021

Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M
Natan Ponieman

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved